This site is intended for healthcare professionals

CDK4/6 inhibitor selection eLearning

Read time: 25 mins

Barbara, Juanita and Emma have all been diagnosed with HR+/HER2- metastatic breast cancer and have been prescribed a CDK4/6 inhibitor. Can you help us select the optimal CDK4/6 inhibitor for each of our three patients?

Register free for full access to